Related content

Combination Chemotherapy with Methotrexate, Etoposide, and Actinomycin D for High-Risk Gestational Trophoblastic Tumors

By Matsui H.   Suzuka K.   Iitsuka Y.   Seki K.   Sekiya S.  

Gynecologic Oncology, Vol. 78, Iss. 1, 2000-07 ,pp. : 28-31

Elsevier

Access to resources Recommend Favorite

The Management of Gestational Trophoblastic Tumors with Etoposide, Methotrexate, and Actinomycin D

By Soto-Wright V.   Goldstein D.P.   Bernstein M.R.   Berkowitz R.S.  

Gynecologic Oncology, Vol. 64, Iss. 1, 1997-01 ,pp. : 156-159

Elsevier

Access to resources Recommend Favorite

Management of Low-Risk Gestational Trophoblastic Tumors with Etoposide (VP16) in Patients Resistant to Methotrexate

By Mangili G.   Garavaglia E.   Frigerio L.   Candotti G.   Ferrari A.  

Gynecologic Oncology, Vol. 61, Iss. 2, 1996-05 ,pp. : 218-220

Academic Press

Access to resources Recommend Favorite

Effectiveness of novel combination chemotherapy, consisting of 5-fluorouracil, vincristine, cyclophosphamide and etoposide, in the treatment of low-grade gliomas in children

By Lee Mee   Ra Young   Park Jun   Goo Hyun   Ahn Seung   Khang Shin   Song Joon   Kim Yoon   Ghim Thad  

Journal of Neuro-Oncology, Vol. 80, Iss. 3, 2006-12 ,pp. : 277-284

Springer Publishing Company

Access to resources Recommend Favorite

Weekly Intravenous Methotrexate with Folinic Acid for Nonmetastatic Gestational Trophoblastic Neoplasia

By Kwon J.S.   Elit L.   Mazurka J.   Moens F.   Schmuck M.L.  

Gynecologic Oncology, Vol. 82, Iss. 2, 2001-08 ,pp. : 367-370

Elsevier

Access to resources Recommend Favorite